Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are caused by a somatic gain-of-function mutation in 1 of the 3 disease driver genes JAK2, MPL, or CALR. About half of the MPNs patients also carry additional somatic mutations that modify the clinical course. The order of acquisition of these gene mutations has b...
Main Authors: | Damien Luque Paz, Michael S. Bader, Ronny Nienhold, Shivam Rai, Tiago Almeida Fonseca, Jan Stetka, Hui Hao-Shen, Gabriele Mild-Schneider, Jakob R. Passweg, Radek C. Skoda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000885 |
Similar Items
-
Mouse models of myeloproliferative neoplasms for pre-clinical testing of novel therapeutic agents
by: Jan Stetka, et al.
Published: (2021-03-01) -
Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm
by: Shivam Rai, et al.
Published: (2022-09-01) -
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01) -
Genetic lineage tracing in clonal haematopoiesis and myeloproliferative neoplasms
by: Sousos, N
Published: (2023) -
Classification and personalized prognosis in myeloproliferative neoplasms
by: Grinfeld, J, et al.
Published: (2018)